Grand-Pa recall not in Namibia

PHARMACEUTICAL company GlaxoSmithKline (GSK) is recalling all Grand-Pa headache powders after it was found that counterfeit products may be circulating in South Africa.

‘GSK is advising consumers and retailers to check all Grand-Pa powders 38-count in their possession for … batch numbers 309339 and 314020,’ said GSK spokesperson Dave Thomas.’The affected product should not be used, as counterfeit medicines were not subjected to the rigorous safety and quality checks by GSK, as is the case with genuine Grand-Pa powders.’ The products were discovered in early July when police raided a counterfeit facility in the Free State, Thomas said. It was found that the counterfeit products had two legitimate batch numbers.’To be safe, we’re asking consumers to immediately stop using the affected batch numbers of Grand-Pa product,’ he said.He said analysis is under way in GSK laboratories in the UK to determine the contents of the counterfeit products, and the results were expected ‘later this week or early next week’.’GSK Consumer Healthcare continues to work diligently to ensure quality, genuine products for the South African market,’ he said. When called for comment on whether this recall will affect Namibia, The Namibia Medicines Regulatory Council denied any knowledge of any recall in Namibia.Glasko- Smithe Klein South Africa called on consumers who suspected that they have fake Grand-Pa products to call them on their help- line +027 0800-118274.- www.witness.co.za

In an age of information overload, Sunrise is The Namibian’s morning briefing, delivered at 6h00 from Monday to Friday. It offers a curated rundown of the most important stories from the past 24 hours – occasionally with a light, witty touch. It’s an essential way to stay informed. Subscribe and join our newsletter community.

The Namibian uses AI tools to assist with improved quality, accuracy and efficiency, while maintaining editorial oversight and journalistic integrity.